Sorafenib, Risk of Bleeding and Spontaneous Rupture of Hepatocellular Carcinoma. A Clinical Case Articles by the same authors

Acta Medica > Archive > 2011, Vol. 54 > Issue 4 > p. 177 > Articles by the same authors

Acta Med. 2011, 54: 177-179

https://doi.org/10.14712/18059694.2016.46

Sorafenib, Risk of Bleeding and Spontaneous Rupture of Hepatocellular Carcinoma. A Clinical Case

Ferdinando Rombolà^a, Angelo Caravetta^b, Francesco Mollo^c, Antonio Spinoso^d, Lenino Peluso^c, Raffaele Guarino^b

^aEmergency Medicine Unit, “Jazzolino” Hospital, Vibo Valentia, and Postgraduate Internal Medicine School, Faculty of Medicine, University of Messina, Italy
^bGeneral Surgery Unit, “Beato Angelo” Hospital, Acri, Cosenza, Italy
^cEmergency Unit, “Beato Angelo” Hospital, Acri, Cosenza, Italy
^dOncology Unit, ASP Vibo Valentia, Italy

Received November 12, 2010
Accepted October 27, 2011